Rodec Pharma͏ IPO

Rodec Pharma Limited is an established entity in the Indian animal healthcare sector, with a history of over 28 years. The company operates through an integrated business model that covers the manufacturing of animal feed supplements and the marketing of veterinary pharmaceutical drugs.

• Rodec Pharma Limited The company boasts a comprehensive portfolio of 35 products with 29 variants. These products span across key categories, including:

• • Antibiotics

• • Analgesics & Antipyretics

• • Anthelmintics

• • Ectoparasiticides

• • Animal Feed Supplements (manufactured in-house)

• • Herbal products

• Manufacturing Capabilities:

• • The company’s manufacturing facility for animal feed supplements is located in Ghaziabad, Uttar Pradesh.

• • This facility is certified under Fami-QS and ISO standards, underscoring its commitment to quality.

• • A portion of its pharmaceutical drugs are procured from third-party manufacturers, with stringent quality checks in place.

• Distribution Network and Reach:

• • Rodec Pharma Limited has a strong pan-India presence across 15 states, including Uttar Pradesh, Maharashtra, Haryana, Punjab, Gujarat, Rajasthan, and West Bengal.

• • Distribution Infrastructure: As of December 31, 2025, the company’s network includes:

• • 13 Consignee Agents: Operate under formal agreements with adequate storage facilities.

• • 401 Stockists: Focused on the states of Uttar Pradesh and Uttarakhand for last-mile delivery.

• • 416 Veterinary Sales Representatives (VSRs): Regular employees responsible for promotion and sales.

• • Revenue Drivers: The North region, particularly Uttar Pradesh, remains a key revenue generator, contributing approximately 49.77% of revenue from operations for the period ended September 30, 2025.

• Strategic Focus:

• • Poultry Segment Entry: A significant recent development is the partnership with Bluejais B.V. to act as its exclusive distributor in India for poultry nutrition products like Moistal and Acidro-H. This move diversifies the company’s revenue base beyond the livestock segment.

• • Educational Initiatives: The company’s “Uttam Pashudhan, Samridh Kisan” program is a unique initiative that directly engages with farmers, providing guidance on animal nutrition, disease control, and dairy management, thereby fostering brand loyalty.

Industry Outlook

The Indian animal healthcare industry is poised for robust growth, driven by several structural factors. The sector, encompassing veterinary pharmaceuticals and feed supplements, is projected to grow at a CAGR of 12-14% over the next five years. A key driver is the increasing commercialization of livestock and poultry farming in India. As traditional farming gives way to organized, semi-organized units, there is a greater focus on disease prevention, herd health management, and productivity, leading to higher adoption of veterinary drugs and supplements.

Furthermore, rising disposable incomes and a growing awareness of animal protein consumption are increasing the demand for high-quality milk, meat, and eggs. This, in turn, pressures farmers to maintain the health and productivity of their livestock. The government’s focus on increasing livestock productivity through various schemes also provides a supportive policy environment. Within this growing industry, products like antibiotics, nutritional supplements, and specialized poultry feed additives, which constitute Rodec Pharma’s core portfolio, are witnessing the highest demand, creating a favorable tailwind for specialized players in the sector.

How Will Rodec Pharma Limited Benefit

• Rodec Pharma Limited will benefit from the 12-14% CAGR growth in the Indian animal healthcare sector, gaining a larger share of a rapidly expanding market.

• The company is well-positioned to capitalize on the increasing commercialization of dairy and poultry farming, which drives demand for its specialized products.

• Its strategic entry into the high-growth poultry segment through the Bluejais partnership will allow it to diversify its revenue streams beyond its traditional livestock focus.

• As the demand for high-quality animal protein rises, the need for Rodec Pharma’s nutritional supplements and disease management products will correspondingly increase.

• The government’s focus on livestock productivity will create a supportive environment, potentially leading to increased adoption of veterinary products in rural areas.

• The company’s existing stronghold in the North region can be leveraged as a base to expand into under-penetrated markets, capturing new customer segments.

• The trend towards preventive animal healthcare will boost demand for the company’s educational programs, which in turn drive brand loyalty and product adoption.

• Rodec Pharma’s focus on quality, evidenced by its ISO-certified facility, aligns with the growing end-user preference for reliable and efficacious veterinary solutions.

Peer Group Comparison

Name of the Company	Face Value (₹ )	Revenue (₹ in million)	EPS (₹ )	NAV (₹)	P/E Ratio	RoNW (%)
Rodec Pharma Limited	10	1,063.93	8.08	22.15	[●]	36.49
Peer Group
Hester Biosciences Limited	10	3,111.02	33.89	383.99	46.05	8.82
Sequent Scientific Limited	2	15,513.70	0.85	30.78	233.61	4.19
Alembic Pharmaceuticals Limited	2	66,720.80	29.68	264.03	26.95	11.22

Key Strategies for Rodec Pharma Limited

Market Reach Expansion and Distribution Network Strengthening

Rodec Pharma Limited is committed to expanding its geographical footprint into under-penetrated states with substantial livestock populations. The strategy involves onboarding additional consignee agents, stockists, and VSRs to enhance product availability and reduce delivery timelines, aiming to capture a larger share of the growing veterinary pharmaceutical market and establish itself as a recognized pan-India brand.

Cost Efficiency and Operational Excellence

In a price-sensitive market, Rodec Pharma Limited focuses on enhancing cost efficiency across its value chain. This includes leveraging its growing scale to negotiate better pricing with suppliers and implementing digital tools for order management and customer relationship management. These efforts are aimed at eliminating inefficiencies to deliver better customer value while protecting profitability.

Entry into Poultry Segment

Recognizing the increasing commercialisation of poultry farming in India, Rodec Pharma Limited is diversifying into this high-potential segment. Through its exclusive distribution agreement with Bluejais B.V., the company is gaining access to specialized poultry nutrition products. This strategic move is expected to create additional revenue opportunities and reduce the company’s concentration in the livestock segment.